In a review focused on the hallmarks of cancer expression in OLP patients, one of the key molecular mechanisms driving epithelial cell proliferation is initiated by the binding of epidermal growth factor (EGF) to its receptor, epidermal growth factor receptor (EGFR), triggering a cascade of downstream hyperproliferative events (15). The gene discussed is EGFR; the disease is cancer.